Copalia HCT
Active substance: amlodipine, valsartan, hydrochlorothiazide
amlodipine, valsartan, hydrochlorothiazide
Centralised EU authorisationActive
Marketing holder: Novartis Europharm Limited
Verified 2026-10-09 · EMA
Analogues in other countries- Source: EMA
- Countries with the substance registered: 3
Composition
Products containing amlodipine in other countries
Showing products with this active substance, combinations included; the full composition is shown for each product.
| Country | Products |
|---|---|
| RU 236 |
|
| US 560 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-2735-7854-bd36-a26bf61cb5f9,01a1208c-2d37-7214-ac62-f56eeb97784e,01a1208c-30bf-7929-b49f-e75adac378a7,01a1208c-34f5-7233-a33f-b013f249c17f,01a1208c-34f6-7f74-82a3-74deb7d90815;count=196 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- EMEA/H/C/001159
- Registration status
- Active
- ATC code
- C09DX01
Sources
- product · EMA · EMEA/H/C/001159 · Verified 2026-10-09
- registration_status · EMA · EMEA/H/C/001159 · Verified 2026-10-09
- ingredients.0 · EMA · EMEA/H/C/001159 · Verified 2026-10-09
- ingredients.1 · EMA · EMEA/H/C/001159 · Verified 2026-10-09
- ingredients.2 · EMA · EMEA/H/C/001159 · Verified 2026-10-09